A detailed history of Affinity Asset Advisors, LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 525,000 shares of VRDN stock, worth $10.3 Million. This represents 2.06% of its overall portfolio holdings.

Number of Shares
525,000
Previous 150,000 250.0%
Holding current value
$10.3 Million
Previous $1.95 Million 512.15%
% of portfolio
2.06%
Previous 0.27%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$12.16 - $23.33 $4.56 Million - $8.75 Million
375,000 Added 250.0%
525,000 $11.9 Million
Q2 2024

Aug 14, 2024

BUY
$11.6 - $17.26 $1.74 Million - $2.59 Million
150,000 New
150,000 $1.95 Million
Q4 2023

Feb 13, 2024

BUY
$11.12 - $22.5 $556,000 - $1.13 Million
50,000 New
50,000 $1.09 Million
Q2 2022

Aug 12, 2022

SELL
$9.55 - $19.0 $280,197 - $557,460
-29,340 Reduced 58.68%
20,660 $239,000
Q1 2022

May 13, 2022

BUY
$16.79 - $20.88 $839,500 - $1.04 Million
50,000 New
50,000 $925,000

Others Institutions Holding VRDN

About Viridian Therapeutics, Inc.\DE


  • Ticker VRDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,888,900
  • Market Cap $785M
  • Description
  • Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...
More about VRDN
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.